Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection

Journal of Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 360-364

  Pascual, Liliana ^a   Ruiz, Francisco ^a   Giordano, Walter ^a   Barberis, Isabel Lucila ^a  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOBACILLUS FERMENTUM L23; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; IN VIVO STUDY; INHIBITION KINETICS; LACTOBACILLUS FERMENTUM; MICROBIAL ACTIVITY; NONHUMAN; PREMENOPAUSE; PRIORITY JOURNAL; VAGINA; VAGINITIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIOCINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LACTOBACILLUS FERMENTUM; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROBIOTICS; SEQUENCE ANALYSIS, DNA; VAGINA; VAGINITIS;

EID: 76649123899     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.012583-0     Document Type: Article

References (32)

1. Alander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T. & von Wright, A. (1999). Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65, 351-354.
2. Asahara, T., Nomoto, K., Watanuki, M. & Yokokura, T. (2001). Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45, 1751-1760.
3. Bergey's Manual of Determinative Bacteriology (1994). 9th edn, pp. 71-174, 175-289, 527-558. Edited by J. G. Holt. Baltimore: Williams & Wilkins.
4. Chan, R. C., Reid, G., Irvin, R. T., Bruce, A. W. & Costerton, J. W. (1985). Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47, 84-89.
5. Colodner, R., Edelstein, H., Chazan, B. & Raz, R. (2003). Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 5, 767-769.
6. Czaja, C. A., Stapleton, A. E., Yarova-Yarovaya, Y. & Stamm, W. E. (2007). Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol 2007, 35387.
7. de Champs, C., Maroncle, N., Balestrino, D., Rich, C. & Forestier, C. (2003). Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 41, 1270-1273.
8. Forbes, B. A., Sahm, D. F. & Weissfeld, A. (2004). Bailey & Scott's Diagnostic Microbiology, 11th edn, pp. 297, 379. St Louis, MO: Mosby.
9. Foxman, B. (2002). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113, 5-13.
10. Kontiokari, T., Sundqvist, K., Nuutinen, M., Pokka, T., Koskela, M. & Uhari, M. (2001). Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322, 1571.
11. Lennette, E. H., Ballows, A., Hausler, W. J. & Shadomy, H. J. (editors) (1987). Manual of Clinical Microbiology, 4th edn, pp. 336-359. Washington, DC: American Society for Microbiology.
12. Mastromarino, P., Brigidi, P., Macchia, S., Maggi, L., Pirovano, F., Trinchieri, V., Conte, U. & Matteuzzi, D. (2002). Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 93, 884-893.
13. McGrory, T. & Garber, G. E. (1992). Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection. Infect Immun 60, 2375-2379.
14. Meysick, K. C. & Garber, G. E. (1992). Interactions between T. vaginalis and vaginal flora in a mouse model. J Parasitol 78, 157-160.
15. Nigatu, A., Ahrne, S. & Molin, G. (2000). Temperature- dependent variation in API 50 CH fermentation profiles of Lactobacillus species. Curr Microbiol 41, 21-26.
16. Pascual, L. M. (2004). Bacteriocinogenia en el género Lactobacillus: caracter?́sticas benéficas de lactobacilos de vagina humana. Doctoral thesis, Universidad Nacional de Río Cuarto, Argentina.
17. Pascual, L. M., Daniele, M. B., Giordano, W., Pajaro, M. C. & Barberis, I. L. (2008a). Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr Microbiol 56, 397-402.
18. Pascual, L. M., Daniele, M. B., Ruiz, F., Giordano, W., Pajaro, C. & Barberis, L. (2008b). Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina. J Gen Appl Microbiol 54, 141-148.
19. Pavan, S., Desreumaux, P. & Mercenier, A. (2003). Use of mouse models to evaluate the persistence, safety and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol 10, 696-701.
20. Peran, L., Sierra, S., Cmalada, M., Lara Villoslada, F., Bailo´n, E., Nieto, A., Concha, C., Olivares, M., Zarzuelo, A. & other authors (2007). A comparative study of the preventive effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97, 96-103.
21. Reid, G. (2001). Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73, 437S-443S.
22. Reid, G. (2002). Probiotics for urogenital health. Nutr Clin Care 5, 3-8.
23. Reid, G., Jass, J., Sebulsky, M. T. & McCormick, J. K. (2003). Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16, 658-672.
24. Reid, G., Anand, S., Bingham, M., Wadstrom, T., Fuller, R., Anukam, K. & Katsivo, M. (2005). Probiotics for the developing world. J Clin Gastroenterol 39, 485-488.
25. Roos, V., Ulett, G., Schembri, M. & Klemm, P. (2006). The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 74, 615-624.
26. Silva de Ruiz, C., Rey, M. del R. & Nader-Macías, M. (2003). Structural and ultrastructural studies of the urinary tract of mice inoculated with Lactobacillus fermentum. BJU Int 91, 878-882.
27. Vintiñi, E., Ocana, V. & Nader-Macias, M. (2004). Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response to local administration of selected strains. Methods Mol Biol 268, 401-410.
28. Wagner, R. D., Pierson, C., Warner, T., Dohnalek, M., Farmer, J., Roberts, L., Hilty, M. & Balish, E. (1997a). Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 65, 4165-4172.
29. Wagner, R. D., Warner, T., Roberts, L., Farmer, J. & Balish, E. (1997b). Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun 65, 3345-3351.
30. Watt, S., Lanotte, P., Mereghetti, L., Moulin-Schouleur, M., Picard, B. & Quentin, R. (2003). Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors. J Clin Microbiol 41, 1929-1935.
31. Xie, J., Foxman, B., Zhang, L. & Marrs, C. (2006). Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder. J Clin Microbiol 44, 2434-2441.
32. Za´rate, G., Santos, V. & Nader-Macias, M. E. (2007). Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol 2007, 48358.